First in vitro data on new emerging Omicron variants consistent with Evusheld’s neutralisation activity…
Tag:
AstraZeneca
-
-
Lifestyle & Healthslider
AstraZeneca COVID-19 vaccine approved in the EU as third dose booster against COVID-19
by Karine Ayoubby Karine AyoubApproval follows CHMP recommendation for use in patients previously vaccinated with AstraZeneca COVID-19 vaccine…
-
Lifestyle & Healthslider
Joint Statement on the Impact of COVID-19 on Immunocompromised Patients
by Karine Ayoubby Karine AyoubGlobal patient groups call on governments and health system leaders to address the unmet…
-
Lifestyle & Healthslider
Evusheld significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populations
by Karine Ayoubby Karine AyoubPre-exposure prophylaxis (prevention) trial reduced risk of symptomatic COVID-19, with no severe disease or…
-
Lifestyle & Healthslider
Evusheld long-acting antibody combination approved in the EU for pre-exposure prophylaxis (prevention) of COVID-19 in a broad population
by Karine Ayoubby Karine AyoubEvusheld significantly reduced the risk of developing symptomatic COVID-19 in PROVENT Phase III trial,…
-
Lifestyle & Healthslider
AstraZeneca launches global R&D Postdoctoral Challenge to accelerate scientific discovery and diversity
by Karine Ayoubby Karine AyoubSuccessful proposals will secure fully funded postdoctoral research positions AstraZeneca today launched a global…
-
Lifestyle & Healthslider
Enhertu significantly improved both progression-free and overall survival in DESTINY-Breast04 trial in patients with HER2-low metastatic breast cancer
by Karine Ayoubby Karine AyoubFirst HER2-low metastatic breast cancer Phase III results for AstraZeneca and Daiichi Sankyo’s Enhertu…
-
Lifestyle & Healthslider
Update on agreement to supply US with additional doses of Evusheld, a long-acting antibody combination
by Karine Ayoubby Karine AyoubEvusheld has emergency use authorisation for pre-exposure prophylaxis (prevention) of COVID-19 AstraZeneca today welcomes…
-
Lifestyle & Healthslider
New AstraZeneca COVID-19 vaccine data further support its use as third dose booster
by Karine Ayoubby Karine AyoubNew data from ongoing trial showed increased antibody response against Beta, Delta, Alpha and…
-
Lifestyle & Healthslider
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in independent FDA study
by Karine Ayoubby Karine AyoubOnly antibody authorised in the US for pre-exposure prophylaxis of COVID-19 AstraZeneca’s Evusheld (tixagevimab…
Newer Posts